Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Swiss pharmaceutical firm Novartis AG plans to invest $23 billion in the US over the next five years to ensure its key drugs ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump threatened to impose tariffs on foreign drugs. The company announced ...

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...